Jabra Enhance Pro 20 at Costco vs Otofonix Encore

The Jabra Enhance Pro 20 at Costco is a prescription behind-the-ear hearing aid available for $1,600, earning an A grade with a SoundScore of 4.0/5 in our lab testing. This places it in the top 61% of the 36 prescription hearing aids we've evaluated. In our testing, this device shows a mixed performance profile. Own-voice comfort is a clear strength, scoring 3.5/5—0.75 points above the category average—making it a solid choice for users who prioritize natural sound quality when speaking. Feedback handling is excellent at 4.8/5, slightly above the category average, indicating stable performance during typical daily activities. However, speech-in-noise performance is notably limited, scoring just 1.1/5—0.82 points below the category average of 1.96. This is a meaningful weakness for users who frequently encounter noisy environments like restaurants or social gatherings. Speech in quiet is solid at 3.2/5, though slightly below the category average. Music streaming scores 2.8/5, above average but only mixed in absolute terms. At this price point, buyers should consider alternatives. The Rexton Reach R-Li T80 at Costco scores 4.58/5 in the same price range, while lower-priced options like the Lexie B3 (4.76/5) offer stronger overall performance. The Jabra Enhance Pro 20 may suit users who prioritize own-voice comfort and feedback stability over challenging listening environments, but those needing robust noise handling should explore other options.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.